Related Experiment Video
Updated: Oct 24, 2026

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
Published on: February 9, 2019
Hollow Mesoporous Polydopamine Nanocarriers Loaded With Curcumin Nanoparticles Modulate Macrophage Polarization and
Juan Zhang1,2, Chenglong Yin1,2, Jinghong Chen2,3
1Department of Stomatology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Abstract:
Periodontitis is a chronic inflammatory disease driven by dysregulated host immune responses. Macrophages, as key innate immune cells, play important roles in periodontal inflammation and bone homeostasis, and M2-like macrophage polarization has been associated with improved osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs). Curcumin possesses anti-inflammatory and bone-protective properties, but its application is limited by poor aqueous solubility, chemical instability, and low bioavailability. In this study, curcumin nanoparticles (CUR NPs) were prepared by a reprecipitation/nanoprecipitation method and encapsulated into hollow mesoporous polydopamine (HMPDA) to construct HMPDA-CUR NPs. The resulting nanoparticles showed improved aqueous dispersibility, favorable biocompatibility, and sustained-release behavior. In vitro experiments showed that HMPDA-CUR NPs promoted the shift of lipopolysaccharide (LPS)-stimulated RAW264.7 macrophages from an M1-like pro-inflammatory phenotype toward an M2-like anti-inflammatory phenotype, with downregulation of M1-related markers and upregulation of M2-related markers. Conditioned medium from HMPDA-CUR NP-treated macrophages further enhanced osteogenic differentiation of BMSCs. Transcriptomic and RT-qPCR analyses showed that CUR NPs upregulated Acat3 and several fatty acid oxidation-related genes, indicating an association between CUR NP treatment and FAO-related metabolic remodeling. Direct FAO flux was not assessed in the present study. In a rat ligature-induced periodontitis model, HMPDA-CUR NPs showed a non-significant trend toward alleviating alveolar bone loss, indicating that the local delivery strategy requires further optimization. Overall, HMPDA-CUR NPs represent a promising immunomodulatory nanosystem for improving the periodontal bone-regenerative microenvironment, although additional mechanistic and delivery-optimization studies are required before translational application.